Panacea Biotec has informed that Shantanu Yeshwant Nalavadi, Non-Executive Nominee Director of the Company has, due to his professional commitments, tendered resignation from the Board of Directors of the Company vide his letter dated March 10, 2022. Shantanu Yeshwant Nalavadi was earlier nominated by Vistra ITCL (India) acting as Debenture Trustee with respect to non-convertible debentures issued to India Resurgence Fund-Scheme 1, India Resurgence Fund-Scheme 2 and Piramal Enterprises which have been fully redeemed on March 03,2022. The said resignation has become effective from March 10, 2022.
The above information is a part of company’s filings submitted to BSE.
